Bicocca Open Archive

Logo unimib boa
PERSEGHIN, GIANLUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.656
AS - Asia 13.021
EU - Europa 8.437
SA - Sud America 1.856
AF - Africa 330
OC - Oceania 60
Continente sconosciuto - Info sul continente non disponibili 16
Totale 40.376
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.406
SG - Singapore 4.829
CN - Cina 2.661
IT - Italia 2.404
HK - Hong Kong 1.918
RU - Federazione Russa 1.503
VN - Vietnam 1.401
BR - Brasile 1.387
CA - Canada 1.083
IE - Irlanda 936
DE - Germania 899
SE - Svezia 815
BD - Bangladesh 535
GB - Regno Unito 437
FR - Francia 399
IN - India 396
UA - Ucraina 239
ID - Indonesia 184
FI - Finlandia 177
AR - Argentina 173
IQ - Iraq 148
KR - Corea 145
TR - Turchia 142
AT - Austria 119
PK - Pakistan 112
NL - Olanda 109
JP - Giappone 99
ZA - Sudafrica 99
MX - Messico 87
EC - Ecuador 72
CO - Colombia 66
PH - Filippine 66
ES - Italia 65
SA - Arabia Saudita 65
PL - Polonia 63
CH - Svizzera 58
AU - Australia 54
DK - Danimarca 51
EG - Egitto 45
UZ - Uzbekistan 42
BE - Belgio 40
MY - Malesia 40
VE - Venezuela 40
CL - Cile 37
MA - Marocco 34
JO - Giordania 31
KE - Kenya 27
PY - Paraguay 25
IR - Iran 21
AE - Emirati Arabi Uniti 20
DZ - Algeria 20
TN - Tunisia 20
UY - Uruguay 20
NP - Nepal 19
PE - Perù 19
TH - Thailandia 19
TW - Taiwan 19
AZ - Azerbaigian 18
PT - Portogallo 18
RO - Romania 18
KZ - Kazakistan 15
PA - Panama 15
CZ - Repubblica Ceca 14
ET - Etiopia 14
OM - Oman 14
BG - Bulgaria 13
IL - Israele 13
CR - Costa Rica 12
LB - Libano 12
NG - Nigeria 12
BO - Bolivia 10
GR - Grecia 10
GT - Guatemala 9
LT - Lituania 9
NI - Nicaragua 9
DO - Repubblica Dominicana 8
SN - Senegal 8
CI - Costa d'Avorio 7
EU - Europa 7
HN - Honduras 7
HR - Croazia 7
JM - Giamaica 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AO - Angola 5
BY - Bielorussia 5
GE - Georgia 4
GY - Guiana 4
KG - Kirghizistan 4
LA - Repubblica Popolare Democratica del Laos 4
NO - Norvegia 4
RS - Serbia 4
TT - Trinidad e Tobago 4
ZM - Zambia 4
ZW - Zimbabwe 4
AL - Albania 3
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BH - Bahrain 3
Totale 40.300
Salva come PNG Salva come JPEG
Città #
Singapore 2.658
Hong Kong 1.876
Ann Arbor 1.572
Ashburn 1.138
Chandler 997
San Jose 944
Toronto 900
Dublin 880
Santa Clara 744
Milan 676
Fairfield 666
Frankfurt am Main 643
New York 643
Beijing 526
Chicago 496
Wilmington 423
Woodbridge 420
Princeton 392
Ho Chi Minh City 391
Dearborn 375
Houston 368
Hanoi 340
Jacksonville 324
Los Angeles 303
The Dalles 298
Dallas 288
Hefei 276
Seattle 236
Lauterbourg 227
Cambridge 217
Altamura 194
Lawrence 193
Hangzhou 182
Rome 163
Nanjing 156
Council Bluffs 139
Moscow 137
Boardman 132
Buffalo 127
Jakarta 127
Helsinki 126
Seoul 119
São Paulo 116
San Diego 113
Shanghai 104
London 91
Vienna 87
Guangzhou 83
Andover 67
Orem 66
Munich 63
Tokyo 60
Baghdad 58
Salt Lake City 53
Shenyang 53
Da Nang 52
Atlanta 51
Haiphong 51
Rio de Janeiro 50
Zurich 50
Montreal 47
Nanchang 45
Dhaka 42
Dong Ket 42
Warsaw 42
Bari 41
Naples 40
San Francisco 40
Turin 40
Phoenix 38
Tashkent 37
Changsha 36
Johannesburg 36
Hebei 35
Brussels 34
Denver 34
Hải Dương 34
Nuremberg 34
Biên Hòa 33
Brooklyn 33
Elk Grove Village 32
Lappeenranta 32
Mumbai 32
Riyadh 32
Falls Church 31
Lahore 31
Tianjin 31
Norwalk 30
Tampa 30
Brasília 29
Istanbul 29
Stockholm 29
Chennai 28
Amman 27
Monza 27
Bologna 26
Jiaxing 25
Jinan 25
New Delhi 25
Pune 25
Totale 24.639
Salva come PNG Salva come JPEG
Nome #
From NAFLD to MAFLD and MASLD: a tale of alcohol, stigma and metabolic dysfunction 619
NAFLD/NASH in patients with type 2 diabetes and related treatment options 582
Differential Association of Sex Hormones with Metabolic Parameters and Body Composition in Men and Women from the United States 458
Is Switching from Oral Antidiabetic Therapy to Insulin Associated with an Increased Fracture Risk? 457
Exploring the landscape of steatotic liver disease in the general US population 438
Metabolic dysfunction-associated steatotic liver disease, insulin sensitivity and continuous glucose monitoring metrics in patients with type 1 diabetes: A multi-centre cross-sectional study 416
Activation of angiotensin type 2 (AT2) receptors prevents myocardial hypertrophy in Zucker diabetic fatty rats 352
Endocrinology and Metabolic Diseases (Including Diabetes) 348
Fasting whole-body energy homeostasis and hepatic energy metabolism in nondiabetic humans with fatty liver 327
Adherence to clinical evaluations in women with pre-existing diabetes during pregnancy: A call to action from an Italian real-life investigation 290
Resting Energy Expenditure in Obese Women with Primary Hypothyroidism and Appropriate Levothyroxine Replacement Therapy 287
Renal Anti-Fibrotic Effect of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent Hypertension 275
Malattie delle paratiroidi e del metabolismo fosfo-calcico - Ipoparatiroidismo 265
Cost-effectiveness of the adherence with recommendations for clinical monitoring of patients with diabetes 261
Resting Whole Body Energy Metabolism in Class 3 Obesity; from Preserved Insulin Sensitivity to Overt Type 2 Diabetes 258
Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population 257
[OP.4B.05] MIR-30A-3P EXPRESSION IN THE HEARTS OF DIABETIC RATS 257
Comparing medication persistence with oral and subcutaneous semaglutide in a real-world setting 245
Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy 238
Sympathetic neural abnormalities in type 1 and type 2 diabetes: a systematic review and meta-analysis 233
High Prevalence of Advanced Liver Fibrosis Assessed by Transient Elastography Among U.S. Adults With Type 2 Diabetes 229
Advancements in pharmacological treatment of NAFLD/MASLD: a focus on metabolic and liver-targeted interventions 227
Adherence to GLP1-RA and SGLT2-I affects clinical outcomes and costs in patients with type 2 diabetes 221
Brief report: Serum retinol-binding protein-4, leptin, and adiponectin concentrations are related to ectopic fat accumulation 219
The Role of Natriuretic Peptides in the Management of Heart Failure with a Focus on the Patient with Diabetes 218
Compassionate use of Ruxolitinib in patients with SarsCov-2 infection not on mechanical ventilation. Short-term effects on inflammation and ventilation 218
Anomalous leucine metabolism in total lipoatrophic diabetes: a possible mechanism of muscle mass hypertrophy 215
Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver 215
Seasonal variation in estimated cardiovascular risk in patients with type 2 diabetes 213
Impact of MASLD and MetALD on clinical outcomes: A meta-analysis of preliminary evidence 212
Effect of L-Acetylcarnitine on body composition in HIV-related lipodystrophy 212
Non-alcoholic fatty liver disease: A risk factor for myocardial dysfunction? 211
Effect of the sporting discipline on the right and left ventricular morphology and function of elite male track runners: A magnetic resonance imaging and phosphorus 31 spectroscopy study 210
Adherence to antidiabetic drug therapy and reduction of fatal events in elderly frail patients 207
Short-term evaluation of cardiac morphology, function, metabolism and structure following diagnosis of adult-onset growth hormone deficiency 206
SGLT2 INHIBITION PREVENTS RENAL FIBROSIS IN CYCLOSPORINE NEPHROPATHY 206
Cardioprotective Effects of Sodium Glucose Cotransporter 2 Inhibition in Angiotensin II-Dependent Hypertension Are Mediated by the Local Reduction of Sympathetic Activity and Inflammation 202
Habitual physical activity is associated with intrahepatic fat content in humans 202
Elevated fasting plasma C-peptide occurs in non-diabetic individuals with fatty liver, irrespective of insulin resistance 199
Hepatitis C virus infection and diabetes: a complex bidirectional relationship 199
Time trends in liver-related mortality in people with and without diabetes: Results from a population based study 197
Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study 196
Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging 196
Prolonged Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes: Results From a Large Population-Based Nested Case-Control Study 196
Noninvasive identification of probable fibrotic nonalcoholic steatohepatitis across the spectrum of glucose tolerance in the United States 195
Abnormal left ventricular energy metabolism in obese men with preserved systolic and diastolic functions is associated with insulin resistance 195
Development of a new model of insulin sensitivity in patients with type 2 diabetes and association with mortality 194
Collaborative synergy in the management of diabetic patients with recent acute coronary syndrome 194
Left ventricular function and energy metabolism in middle-aged men undergoing long-lasting sustained aerobic oxidative training 193
A multi-society Delphi consensus statement on new fatty liver disease nomenclature 192
Screening for non-alcoholic fatty liver disease in type 2 diabetes using non-invasive scores and association with diabetic complications 192
Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD 191
Open questions on basal insulin therapy in T2D: a Delphi consensus 190
Beneficial effects of beta-blockers on left ventricular function and cellular energy reserve in patients with heart failure 190
Lack of awareness of liver organ damage in patients with type 2 diabetes 189
Nonalcoholic Fatty Liver Disease, Liver Fibrosis and Cardiovascular Disease in the Adult US Population 189
Setting up of a machine learning algorithm for the identification of severe liver fibrosis profile in the general US population cohort 188
Implementing metabolic dysfunction-associated steatotic liver disease guidelines in patients with type 2 diabetes 188
The "Early Treatment" Approach Reducing Cardiovascular Risk in Patients with Type 2 Diabetes: A Consensus From an Expert Panel Using the Delphi Technique 188
Preferences, Expectations and Attitudes on Basal Insulin from Patient–Physician–Payer Perspective: A Multi-stakeholder Survey by the Italian Diabetes Society (ITA4P Study) 186
Baseline TSH levels and short-term weight loss after different procedures of bariatric surgery 186
Impaired net hepatic glycogen synthesis in insulin-dependent diabetic subjects during mixed meal ingestion: A 13C nuclear magnetic resonance spectroscopy study 185
Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease 185
Left ventricular function and energy homeostasis in patients with type 1 diabetes with and without microvascular complications 185
Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Screening, Diagnosis, and Treatment 184
A multi-society Delphi consensus statement on new fatty liver disease nomenclature 184
Prevalence of Liver Steatosis and Fibrosis Detected by Transient Elastography in Adolescents in the 2017–2018 National Health and Nutrition Examination Survey 183
A global action agenda for turning the tide on fatty liver disease 182
Effects of atazanavir/ritonavir and lopinavir/ritonavir on glucose uptake and insulin sensitivity [9] 181
Metabolic and psychological features are associated with weight loss 12 months after sleeve gastrectomy 181
Fertilizing a patient engagement ecosystem to innovate healthcare: Toward the first Italian Consensus conference on patient engagement 180
Reduced intrahepatic fat content is associated with increased whole-body lipid oxidation in patients with type 1 diabetes 178
Myocardial metabolism studied during warm blood antero-retrograde reperfusion in ischaemic human hearts 178
Liver fibrosis, NT-ProBNP and mortality in patients with MASLD: a population-based cohort study 176
Increased glucose transport-phosphorylation and muscle glycogen synthesis after exercise training in insulin-resistant subjects 176
Authors' response to Guo, Wei et al. 174
Pazienti diabetici di tipo 2, non in terapia insulinica e albumina glicata: UNA valutazione multidimensionale [Insuline-Naive type 2 diabetic patients: a multidimensional evaluation on the role of glycated albumin] 174
NAIF: A novel artificial intelligence-based tool for accurate diagnosis of stage F3/F4 liver fibrosis in the general adult population, validated with three external datasets 174
NT-ProBNP and mortality across the spectrum of glucose tolerance in the general US population 173
Effect of pancreas transplantation on free fatty acid metabolism in uremic IDDM patients 173
Nonalcoholic Fatty Liver Disease and Advanced Fibrosis in US Adults Across Blood Pressure Categories 172
Liver fibrosis assessed by transient elastography is independently associated with albuminuria in the general United States population 171
NMR studies of muscle glycogen synthesis in insulin-resistant offspring of parents with non-insulin-dependent diabetes mellitus immediately after glycogen-depleting exercise 170
Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors 170
Authors' reply to Zou et al 169
Impact of the duration of type 2 diabetes on the screening for nonal- coholic fatty liver disease and advanced fibrosis 169
Blood pressure, glycemic status and advanced liver fibrosis assessed by transient elastography in the general United States population 169
Persistence of counter‐regulatory abnormalities in insulin‐dependent diabetes mellitus after pancreas transplantation 169
Impact of diabetes on COVID-19-related in-hospital mortality: a retrospective study from Northern Italy 168
Reliability of heart rate in reflecting cardiac sympathetic overdrive in type 2 diabetes mellitus 167
13C/31P NMR studies on the mechanism of insulin resistance in obesity 166
An unexpected bilateral mass after total thyroidectomy 166
Reduced whole-body lipid oxidation is associated with insulin resistance, but not with intramyocellular lipid content in offspring of type 2 diabetic patients 165
Sympathetic Neural Mechanisms Underlying Attended and Unattended Blood Pressure Measurement 165
Serum resistin and hepatic fat content in nondiabetic individuals 164
Metabolic effects of successful intraportal islet transplantation in insulin-dependent diabetes mellitus 164
Mechanism of free fatty acid-induced insulin resistance in humans 163
The roles of insulin and glucagon in the regulation of hepatic glycogen synthesis and turnover in humans 163
Impact of the new definition of metabolic dysfunction–associated fatty liver disease on detection of significant liver fibrosis in US adolescents 163
Lack of feedback inhibition of insulin secretion in denervated human pancreas 162
Totale 21.870
Salva come PNG Salva come JPEG
Categoria #
all - tutte 159.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.269
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021253 0 0 0 0 0 0 0 0 0 0 0 253
2021/20222.371 184 242 429 123 62 136 124 134 146 169 234 388
2022/20233.936 505 925 368 376 272 687 44 234 277 53 105 90
2023/20243.130 182 117 135 215 377 713 543 113 258 68 41 368
2024/20257.927 505 921 442 419 679 336 542 304 706 1.002 737 1.334
2025/202617.937 1.528 1.183 1.304 1.567 1.841 925 2.303 996 1.465 1.417 1.992 1.416
Totale 41.476